Publicité
Publicité

NNNN

NNNN logo

Anbio Biotechnology Class A Ordinary Shares

34.28
USD
Sponsorisé
+2.19
+6.83%
07 janv., 16:00 UTC -5
Fermé
exchange

Après-marché

34.38

+0.09
+0.27%

NNNN Rapports sur les bénéfices

Ratio de surprise positive

Aucune donnée disponible pour NNNN

%

Prochain rapport

Date du prochain rapport
27 avr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Variation implicite de Q-- -- (Revenue/ EPS)
--
/
--
Variation implicite de Q4 24 (Revenue/ EPS)
--
/
--

Anbio Biotechnology Class A Ordinary Shares earnings per share and revenue

On --, NNNN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q-- --, Anbio Biotechnology Class A Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 27 avr. 2026.
Based on -- analystes, Anbio Biotechnology Class A Ordinary Shares is expected to report EPS of -- and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité